AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

The past 3 decades have been characterized by an exponential growth in knowledge and
advances in the clinical treatment of atrial fibrillation (AF). It is now known that AF genesis …

Atrial fibrillation (AF) is the most common arrhythmia (estimated lifetime risk, 22%–26%). The
aim of this article is to review the clinical epidemiological features of AF and to relate them to …

During the past decade, catheter ablation of atrial fibrillation (AF) has evolved rapidly from
an investigational procedure to its current status as a commonly performed ablation …

Background Atrial fibrillation (AF) represents an increasing public health challenge with
profound social and economic implications. Methods A comprehensive synthesis and review …

Atrial fibrillation (AF) is the most common arrhythmia with ever-increasing public health
impact. 1 Over 50 years of observation in the Framingham Heart Study (FHS), there is a 4 …

Atrial fibrillation is a highly prevalent arrhythmia and a major risk factor for stroke, heart
failure and death. We conducted a genome-wide association study (GWAS) in individuals of …

Background—Atrial fibrillation (AF) is the most common cardiac dysrhythmia and a source of
considerable morbidity and mortality, but lifetime risk for AF has not been estimated …

For new or updated text, view the 2011 Focused Update and the 2011 Focused Update on
Dabigatran. Text supporting unchanged recommendations has not been updated. Atrial …

Atrial fibrillation is a condition in which control of heart rhythm is taken away from the normal
sinus node pacemaker by rapid activity in different areas within the upper chambers (atria) of …